These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 27449712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
    Pérez V, Sampor C, Rey G, Parareda-Salles A, Kopp K, Dabezies AP, Dufort G, Zelter M, López JP, Urbieta M, Alcalde-Ruiz E, Catala-Mora J, Suñol M, Ossandon D, Fandiño AC, Croxatto JO, de Dávila MTG, Reaman G, Ravindranath Y, Chantada GL.
    JAMA Ophthalmol; 2018 Jul 01; 136(7):747-752. PubMed ID: 29799944
    [Abstract] [Full Text] [Related]

  • 3. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT.
    Ophthalmology; 1997 Dec 01; 104(12):2101-11. PubMed ID: 9400771
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 Dec 01; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct 01; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 9. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH.
    Br J Ophthalmol; 2013 Oct 01; 97(10):1277-83. PubMed ID: 23863458
    [Abstract] [Full Text] [Related]

  • 10. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
    Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, Vishnubhatla S, Ghose S, Bakhshi S.
    Ophthalmology; 2012 Jul 01; 119(7):1470-7. PubMed ID: 22463820
    [Abstract] [Full Text] [Related]

  • 11. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 12. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA, Sachdev N, Staffieri SE, McKenzie JD, Elder JE.
    J AAPOS; 2015 Feb 15; 19(1):72-4. PubMed ID: 25727592
    [Abstract] [Full Text] [Related]

  • 13. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.
    Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P.
    Pediatr Blood Cancer; 2022 Feb 15; 69(2):e29362. PubMed ID: 34606174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N, Schüler A, Bechrakis N, Henze G, Havers W.
    Klin Padiatr; 1997 Feb 15; 209(4):216-21. PubMed ID: 9293453
    [Abstract] [Full Text] [Related]

  • 19. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT.
    J Clin Oncol; 2000 Jan 15; 18(1):12-7. PubMed ID: 10623688
    [Abstract] [Full Text] [Related]

  • 20. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May 15; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.